Position in GRFS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$104,012
+$42 QoQ
Shares Held
14,691
+13.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 164 holders
Holding Since
Sep 2020
4 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OLD NATIONAL BANCORP /IN/ holds $848,734,090 across 14 Drug Manufacturers - General names. GRFS ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
605,458 | $726,204,549 | |
| 2 | ABBV |
AbbVie Inc.
|
126,179 | $31,751,683 | |
| 3 | JNJ |
Johnson & Johnson
|
99,264 | $25,210,077 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,489 | $18,695,336 | |
| 5 | NVO |
Novo Nordisk A S
|
273,640 | $13,118,301 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
218,238 | $12,574,872 | |
| 7 | PFE |
Pfizer Inc
|
492,066 | $11,848,949 | |
| 8 | AMGN |
Amgen Inc
|
11,639 | $4,214,714 |
All Filings in GRFS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,012 | 14,691 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $103,970 | 12,964 | Shares | Sole | 2026-04-21 | |
| 2020-12-31 | $185,432 | 10,056 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $182,712 | 10,531 | Shares | Sole | 2020-10-29 | |
| No filing history on record for this holder in this stock. | ||||||